Fisetin in Pregnancy and Breastfeeding: What We Know (2026)

Is fisetin safe during pregnancy?

No published safety data exist for fisetin supplementation during pregnancy or breastfeeding. Fisetin naturally occurs in ordinary foods such as strawberries, apples and grapes. Eating appropriately washed fruit as part of an otherwise pregnancy-appropriate diet is different from taking concentrated fisetin capsules; dietary familiarity is not evidence that high-dose fisetin supplements are safe in pregnancy. Concentrated capsule doses are a different matter: they haven't been studied in pregnant or breastfeeding women, and the cautious, honest position is to avoid them without explicit guidance from your obstetric team.

This article separates the two exposures clearly, walks through the theoretical reasons for caution, and gives practical guidance for pregnancy, breastfeeding, and trying to conceive. For the broader safety picture, see our side effects and safety article.

Dietary fisetin versus concentrated supplements

Exposure	How to interpret the evidence
Ordinary fruit and vegetables	Part of a varied pregnancy-appropriate diet when food-safety advice is followed. Fisetin content varies; historical dried-sample data do not give a reliable dose per fresh serving.
Concentrated standalone fisetin capsules or senolytic stacks	No adequately studied maternal, fetal or breastfeeding safety profile. Do not self-prescribe research-level doses.
Already taking a supplement before discovering pregnancy	Bring the product label, actual amount, schedule and concomitant medicines to your obstetric team for individualized advice.

See our food-source analysis for why a strawberry's precise fisetin dose cannot be assumed from an old laboratory table, and the interactions review for the limits of existing medication data.

Why does diet vs supplement matter so much here?

The single most important distinction in this article is between dietary fisetin and supplemental fisetin.

Fisetin occurs naturally in ordinary foods. One historical dietary study estimated roughly 0.4 mg/day among 50 adult women in Japan [1], but this is not a global average. The often-quoted 160 µg/g strawberry figure comes from analyzed freeze-dried, acid-hydrolyzed samples, not a validated fresh-fruit serving dose. Properly washed strawberries, apples and grapes can remain part of an otherwise pregnancy-appropriate diet, but ordinary food exposure does not establish the safety of concentrated fisetin supplements. See our food-source analysis.

A concentrated fisetin supplement is a different exposure entirely. A 500 mg capsule greatly exceeds the approximately 0.4 mg/day intake estimated in the small historical dietary sample; individual dietary intake varies. A human pharmacokinetic trial tested large doses in non-pregnant adults [2], but neither that experiment nor trials in other non-pregnant populations establish maternal, fetal or infant safety.

The practical takeaway: keep the strawberries, stop the capsules.

What are the theoretical concerns with fisetin in pregnancy?

Four biological properties of fisetin raise theoretical concerns in pregnancy. None have been shown to cause harm in humans — because the studies simply haven't been done — but the absence of data is why clinicians default to caution rather than reassurance.

Could fisetin's senolytic activity interfere with pregnancy?

Fisetin is studied for senolytic activity, with selective senescent-cell clearance demonstrated in selected experimental systems rather than established throughout the human body. Cellular senescence isn't just a feature of ageing; it plays specific, necessary roles during pregnancy, including decidualisation, placental development, and the onset of labour [3]. Senescence has a documented beneficial role in normal pregnancy and a harmful one when it becomes dysregulated, which has been linked to complications such as pre-eclampsia and preterm birth. Deliberately clearing senescent cells with a senolytic during pregnancy hasn't been studied, and the theoretical concern is that doing so could interfere with these normal processes. This is speculative, not demonstrated — but it's a reasonable basis for caution.

Could fisetin's effect on drug-metabolising enzymes matter?

Fisetin affects several cytochrome P450 enzymes, including CYP2C8. The placenta uses its own drug-metabolising enzymes to help regulate how much of a medication reaches the fetus. Fisetin's effect on placental enzyme activity hasn't been studied, and a theoretical concern is that it could alter fetal exposure to other medications you're taking. Our drug interactions article covers fisetin's CYP profile in more detail.

Could fisetin's signalling effects affect fetal development?

Fisetin modulates several intracellular signalling pathways involved in fetal development, including PI3K/Akt, NF-κB, and Nrf2 [4]. These pathways regulate normal cell proliferation, differentiation, and programmed cell death during embryonic development. Ordinary dietary exposure is not equivalent to a concentrated supplement dose. Whether supplemental fisetin changes these pathways during human pregnancy is unknown.

Could "more antioxidant" actually be a problem?

Fisetin's antioxidant and anti-inflammatory activity is well established, and it's tempting to assume more antioxidant activity is automatically good in pregnancy. In practice, oxidative and inflammatory signalling are tightly regulated during normal fetal development, and pushing them in one direction pharmacologically isn't automatically protective. Maternal micronutrient status, including antioxidant intake, shapes the epigenetic programming passed on to a child in ways that aren't simply "more is better" [5]. That's a reason for caution with a concentrated antioxidant supplement in pregnancy, not a reason to avoid antioxidant-rich foods.

Is fisetin safe while breastfeeding?

Breastfeeding safety data for fisetin supplementation is essentially absent. Two separate questions are worth answering honestly.

Does fisetin pass into breast milk? No adequately characterized human milk-transfer data exist for fisetin or its metabolites after supplementation. Chemical properties alone cannot quantify infant exposure, and low parent-fisetin concentrations in a small adult pharmacokinetic study do not establish breastfeeding safety.

Would infant exposure matter? Also unknown. Ordinary maternal diets contain flavonoids, but this does not establish infant safety after concentrated fisetin supplementation. Whether supplementation changes milk exposure or infant outcomes has not been studied.

The practical guidance: ordinary fruit is compatible with a varied breastfeeding diet, but this does not establish the safety of concentrated fisetin supplementation. Avoid unsupervised fisetin supplements while breastfeeding; if already using one, stop and consult your own clinician or your child's paediatrician.

Does fisetin affect fertility?

Fisetin's effects on human fertility haven't been studied in a clinical trial. A 2026 review documented early, preclinical evidence for fisetin's effects on ovarian and endometrial tissue as women age, but the review's own authors note that clinical evidence in reproductive health specifically remains absent [6]. Some of the theoretical effects — such as clearing senescent cells from an ageing ovary — are plausible as a benefit, but nothing has been demonstrated in humans.

If you're planning conception, discuss discontinuing concentrated fisetin with your obstetric or fertility clinician. No validated fisetin-specific preconception withdrawal period exists, so a universal one-menstrual-cycle rule should not be presented as evidence-based.

Fisetin's effects on sperm and male fertility have not been adequately studied. Men planning conception should discuss concentrated supplementation with their clinician; there is no evidence-based fisetin washout interval for either partner.

What should you do if you're already pregnant or breastfeeding and taking fisetin?

If you discover you are pregnant while taking concentrated fisetin, stop the supplement and contact your obstetric team, providing the product, dose, timing and any other medicines. Human data are insufficient to quantify fetal risk; exposure does not establish harm, but absence of case reports is not proof of safety. Your obstetric team can advise whether any individualized follow-up is needed.

If you are breastfeeding and discover fisetin in your supplement routine, stop the supplement and contact your own clinician or your child's pediatrician with the product, dose and duration. They can assess whether infant follow-up is appropriate; there is no validated fisetin-specific infant-monitoring protocol.

What we still don't know

Whether supplement-dose fisetin causes any developmental harm during pregnancy, or is entirely harmless, hasn't been tested — the honest answer is that nobody knows yet.

Whether fisetin's senolytic activity meaningfully interferes with the normal role cellular senescence plays in pregnancy and labour [3].

How much fisetin transfers into breast milk, and whether that amount matters for an infant, hasn't been measured.

Whether fisetin affects fertility in either direction — helping, by clearing senescent ovarian cells, or hindering, by interfering with normal follicular biology — is unstudied.

Whether fisetin exposure during pregnancy has any effect on a child's long-term health hasn't been studied at all.

Bottom line

Fisetin supplementation during pregnancy and breastfeeding hasn't been studied. Ordinary fruit in a pregnancy-appropriate diet need not be avoided because it contains fisetin; this is not evidence that concentrated fisetin supplements are safe. Concentrated capsule doses aren't recommended during pregnancy, breastfeeding, or while you're actively trying to conceive. If you become pregnant while taking fisetin, stop and tell your obstetric team. If you're planning pregnancy, discuss discontinuing supplementation before conception with your clinician; no specific fisetin washout interval has been established. This isn't based on evidence of harm — it's based on the complete absence of safety data, and in developmental biology, no evidence isn't the same as evidence of safety. For the broader safety picture, see our side effects and safety article. For the full clinical picture, see our complete clinician's guide.